REGN logo Regeneron : REGN

REGN

Stock Data

$784.36

Change up

$12.25 (1.59%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Regeneron Pharmaceuticals Inc is a biotech firm based in Tarrytown, New York, known for its innovative approach to developing and commercializing medicines for a variety of diseases. The company's portfolio includes treatments for eye conditions like wet age-related macular degeneration, skin diseases such as atopic dermatitis, and other serious ailments including asthma, cardiovascular disease, and certain cancers. Regeneron is also notable for its contributions to infectious disease treatments, including a therapy for COVID-19 and the Ebola virus. Founded in 1988, Regeneron stands out for its commitment to addressing unmet medical needs.

Latest Activity

REGNRegeneron Pharmaceuticals Inc.
Reports Thu Jul 30Before open6:30 AM ETConfirmed

Regeneron reports Q2 results at 6:30 AM ET with investors watching Eylea HD's grip on the wet AMD market against Roche's Vabysmo and the growing shadow of Medicare drug price negotiations on its pipeline.

    All Regeneron Articles

    248 Articles

    1 2 3 17